艾托秒

HistoSonics is a privately held medical device company developing a non-invasive platform and proprietary sonic beam therapy utilizing the science of histotripsy, a novel mechanism of action that uses focused ultrasound to mechanically destroy and liquify unwanted tissue and tumors at sub-cellular levels.In December 2022, HistoSonics Inc announced raised $85 million in a financing led by Johnson & Johnson Innovation with participation from existing investors including Venture Investors, Lumira Ventures, Yonjin Venture, and the State of Wisconsin Investment Board, among others

Owlstone Medical is a developer of a Breath Biopsy platform, which uses breath analysis for precision medicine and the early detection of disease.In September 2021, Owlstone Medical announced the close of its Series D financing round

艾托秒医疗成立于2025年5月9日，是一家专注于医疗器械研发的科技公司。